CYTOSORBENTS CORP : Other Events (form 8-K)

Published: 2022-01-24 16:32:07 ET CTSO

On January 24, 2022, CytoSorbents Corporation (the "Company") issued a press release highlighting a new publication reporting significant reductions in perioperative bleeding complications following acute aortic dissection surgery using the Company's antithrombotic drug removal technology. A copy of the press release is included as Exhibit 99.1 and incorporated by reference herein.

99.1 Press Release of the Company, dated January 24, 2022 104 Cover Page Interactive Data File (embedded with the Inline XBRL document)